We are live on ! Find out more
Rockefeller Capital Management

Rockefeller Capital Management Portfolio holdings

AUM $56.4B
1-Year Est. Return 24.96%
This Fund
S&P 500
This Quarter Est. Return
+9.77%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$19.9B
AUM Growth
+$550M
Cap. Flow
-$983M
Cap. Flow %
-4.94%
Top 10 Hldgs %
17.64%
Holding
4,466
New
207
Increased
1,410
Reduced
1,605
Closed
223

Top Buys

Rank Stock Value
1
AER icon
AerCap
AER
+$54M
2
JPM icon
JPMorgan Chase
JPM
+$45.5M
3
AXP icon
American Express
AXP
+$44.9M
4
META icon
Meta Platforms (Facebook)
META
+$42.9M
5
IBTE
iShares iBonds Dec 2024 Term Treasury ETF
IBTE
+$39.6M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$94.1M
2
RGA icon
Reinsurance Group of America
RGA
+$89.9M
3
NFLX icon
Netflix
NFLX
+$81M
4
LLY icon
Eli Lilly
LLY
+$76.3M
5
GL icon
Globe Life
GL
+$72.8M

Sector Composition

Rank Sector Weight
1 Technology 17.17%
2 Financials 13.41%
3 Healthcare 10.42%
4 Industrials 6.36%
5 Consumer Discretionary 5.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRNE
3501
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$3K ﹤0.01%
3,500
– –
AAT
3502
American Assets Trust
AAT
$1.4B
$2K ﹤0.01%
82
– –
ACHR icon
3503
Archer Aviation
ACHR
$4.26B
$2K ﹤0.01%
1,240
– –
ADAP
3504
DELISTED
Adaptimmune Therapeutics
ADAP
$2K ﹤0.01%
2,000
– –
AGO icon
3505
Assured Guaranty
AGO
$3.34B
$2K ﹤0.01%
38
-80
-68% -$4.74K
AIV
3506
Aimco
AIV
$383M
$2K ﹤0.01%
386
– –
AKBA icon
3507
Akebia Therapeutics
AKBA
$252M
$2K ﹤0.01%
3,771
– –
ALLK
3508
DELISTED
Allakos
ALLK
$2K ﹤0.01%
300
– –
ALTO icon
3509
Alto Ingredients
ALTO
$340M
$2K ﹤0.01%
951
-90
-9% -$320
AMCX icon
3510
AMC Global Media
AMCX
$489M
$2K ﹤0.01%
157
– –
GOLD
3511
Gold.com Inc
GOLD
$1.26B
$2K ﹤0.01%
+65
New +$2.06K
AMRX icon
3512
Amneal Pharmaceuticals
AMRX
$5.79B
$2K ﹤0.01%
1,218
-25
-2% -$56
AOMR
3513
Angel Oak Mortgage REIT
AOMR
$209M
$2K ﹤0.01%
596
+24
+4% +$198
AQST icon
3514
Aquestive Therapeutics
AQST
$494M
$2K ﹤0.01%
3,166
– –
ATOS icon
3515
Atossa Therapeutics
ATOS
$23.5M
$2K ﹤0.01%
+333
New +$3.82K
AVA icon
3516
Avista
AVA
$3.24B
$2K ﹤0.01%
46
-23
-33% -$921
BLOK icon
3517
Amplify Blockchain Technology ETF
BLOK
$1.07B
$2K ﹤0.01%
172
-200
-54% -$3.44K
BOOT icon
3518
Boot Barn
BOOT
$4.95B
$2K ﹤0.01%
46
– –
CBL
3519
CBL Properties
CBL
$1.75B
$2K ﹤0.01%
110
– –
CKPT
3520
DELISTED
Checkpoint Therapeutics
CKPT
$2K ﹤0.01%
529
-1
-0.2% -$7
COLB icon
3521
Columbia Banking Systems
COLB
$8.84B
$2K ﹤0.01%
98
+78
+390% +$2.48K
COOK icon
3522
Traeger
COOK
$172M
$2K ﹤0.01%
17
– –
CPF icon
3523
Central Pacific Financial
CPF
$1B
$2K ﹤0.01%
102
– –
CQQQ icon
3524
Invesco China Technology ETF
CQQQ
$3.31B
$2K ﹤0.01%
46
– –
CSIQ icon
3525
Canadian Solar
CSIQ
$1.08B
$2K ﹤0.01%
77
-169
-69% -$5.68K
139 140
141
142 143

Similar funds

Canada Life
Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
Capstone Investment Advisors
Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Rockefeller Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Rockefeller Capital Management held 4,466 positions worth $19.9B, up 2.8% from $19.3B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Rockefeller Capital Management withdrew a net $983M in Q4 2022, closing 223 positions and reducing 1,605 holdings. Its most notable exit was iShares iBonds Dec 2022 Term Treasury ETF, an estimated $8.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Rockefeller Capital Management opened a new position in First Trust Exchange-Traded Fund VI First Trust Hedged BuyWrite Income ETF worth $5.95M.

  • Rockefeller Capital Management's largest Q4 2022 buy was First Trust Exchange-Traded Fund VI First Trust Hedged BuyWrite Income ETF: 329,901 shares worth $5.95M.
  • Rockefeller Capital Management added most to AerCap in Q4 2022, an estimated $54M increase.
  • Rockefeller Capital Management's biggest Q4 2022 reduction was Medtronic, cutting an estimated $94.1M.
  • Rockefeller Capital Management fully exited iShares iBonds Dec 2022 Term Treasury ETF in Q4 2022, selling an estimated $8.3M.
  • Rockefeller Capital Management's ten largest holdings make up 18% of its $19.9B portfolio in Q4 2022.
  • Rockefeller Capital Management opened 207 new positions and closed 223 in Q4 2022.
  • Rockefeller Capital Management's portfolio value rose 2.8% quarter-over-quarter to $19.9B.

Based on Rockefeller Capital Management's 13F filing for Q4 2022, filed 6 Mar 2023.